期刊文献+
共找到1,217篇文章
< 1 2 61 >
每页显示 20 50 100
Treatment of Irritable Bowel Syndrome by Oral Administration of Chinese Medicines and Retention-Enema——A Report of 50 Cases
1
作者 段国玉 王薇 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2002年第4期262-264,共3页
Irritable bowel syndrome (IBS), a common disease of intestinal dysfunction, is also called emotional enteritis, mucous enteritis, irritable colon and so on1. It is often lingering with a long disease course and is eas... Irritable bowel syndrome (IBS), a common disease of intestinal dysfunction, is also called emotional enteritis, mucous enteritis, irritable colon and so on1. It is often lingering with a long disease course and is easy to recur. The author has in recent years treated 50 cases of the disease by oral administration of Chinese medicines and retention-enema, with satisfactory results reported as follows. 展开更多
关键词 Treatment of Irritable Bowel Syndrome by oral administration of Chinese Medicines and Retention-enema A Report of 50 Cases
下载PDF
Oral Administration Following Subcutaneous Administration of FCV Vaccines Enhances Vaccine Efficacy against Challenge of a Highly Virulent Vs Feline Calicivirus 被引量:2
2
作者 Sing Rong Kim Floyd-Hawkins Vicki King 《World Journal of Vaccines》 2014年第2期81-87,共7页
Feline calicivirus (FCV) is a common cause of upper respiratory and oral disease in cats. Highly virulent systemic strains of FCV (vs FCV) have been described. These vs FCV isolates cause characteristic edema, cutaneo... Feline calicivirus (FCV) is a common cause of upper respiratory and oral disease in cats. Highly virulent systemic strains of FCV (vs FCV) have been described. These vs FCV isolates cause characteristic edema, cutaneous ulcers and other clinical signs typically associated with FCV infection. Vs FCV isolates also cause high mortality even in previously vaccinated cats. We reported previously that the FCV serum cross-neutralization profile of cat serum generated using the oralnasal route of administration is broader than with subcutaneous administration (SC), as measured with a 26-FCV viral panel (Rong et al., Virus Research 122:95-108, 2006). In this report, we tested the in vivo ef- ficacy of the FCV vaccine, in a 4-way (FCV-FHV-FPV-FCp) format, by using a highly virulent vs FCV- 33585 as the challenge virus. Vaccines were administered as 2-dose subcutaneouly (SC/SC), or subcutaneously followed by orally (SC/Oral). The mortality induced by vs FCV-33585 in unvaccinated control cats was 78% (7 out of 9 cats). The mortality decreased to 44% (4 out of 9 cats) with cats vaccinated with the 4-way vaccine given SC/SC. However, when this vaccine was given SC/Oral, the mortality decreased to 10% (1 out of 10 cats). The clinical scores, calculated based on frequency and severity of various clinical signs, correlated with mortality data. These results demonstrated that oral administration of FCV vaccines, as the second dose following the first dose of subcutaneious administration, ehances FCV efficacy against challenge of a highly virulent vs FCV. We propose that not only oral vaccination offers convenience and needle-free inoculation, it also enhances FCV vaccine efficacy. 展开更多
关键词 Positive-Strand RNA FCV VS FCV CALICIVIRUS SUBCUTANEOUS administration oral/Oronasal administration Serum-Virus Neutralization Vaccine Efficacy
下载PDF
Clinical research progress of oral administration of traditional Chinese medicine in the treatment of dry eyes 被引量:2
3
作者 Jin-Xiang Mao Yi-Hua Fan +4 位作者 Hao Lin Li Liu Jia-Yu Huang Xu Wang Xin-Ju Li 《TMR Pharmacology Research》 2021年第3期12-21,共10页
Dry eye is a common and frequently occurring ophthalmology disease with complex etiology and easy recurrence.Oral administration of traditional Chinese medicine has the characteristicsof high curative effect and littl... Dry eye is a common and frequently occurring ophthalmology disease with complex etiology and easy recurrence.Oral administration of traditional Chinese medicine has the characteristicsof high curative effect and little toxic and side effect in the treatment of dry eye.This paper collates the domestic reported clinical studies on the oral administration of traditional Chinese medicine in the treatment of dry eye,which are discussed from four aspects:special prescription for specific disease,addition and subtraction of main prescription,treatment based on syndrome differentiation and proprietary Chinese medicine.The curative effect and advantages of traditional Chinese medicine in the treatment of dry eye are demonstrated,providing a reference for the treatment of dry eye in the future. 展开更多
关键词 dry eye oral administration of Traditional Chinese Medicine clinical research
下载PDF
Pharmacokinetics of Milbemycin Oxime in Dogs Following Its Intravenous and Oral Administration
4
作者 Lu Yi-tong Qi Lian-wen +4 位作者 Xu Qian-qian Ding Liang-jun Wang Bo Liu Hai-rui Li Ji-chang 《Journal of Northeast Agricultural University(English Edition)》 CAS 2018年第1期47-54,共8页
The pharmacokinetics of milbemycin oxime was investigated in dogs following oral(per os, PO) and intravenous(IV) administration. Three groups of dogs received milbemycin oxime tablets as a single PO dose equal to 0.25... The pharmacokinetics of milbemycin oxime was investigated in dogs following oral(per os, PO) and intravenous(IV) administration. Three groups of dogs received milbemycin oxime tablets as a single PO dose equal to 0.25, 0.5 and 1.0 mg · kg-1 of milbemycin oxime, respectively, another group received a single IV dose of 0.5 mg · kg-1. Blood samples were collected at predetermined times after drug administration and the milbemycin oxime concentrations in plasma were determined by LC-MS/MS. The drug protein binding in dog plasma in vitro was determined by equilibrium dialysis at concentrations spanning the range of values observed in vivo in dog plasma. After PO administration at doses of 0.25, 0.5 and 1.0 mg · kg-1, milbemycin oxime was slowly absorbed and eliminated, the time to reach the maximum plasma concentration(Tmax) was 4.14±0.20, 4.27±0.14 and 4.06±0.13 h, the mean absorption time(MAT) was 19.06, 13.67 and 11.77 h, the terminal rate half-life(t1/2λz) was 15.06±0.37, 11.09±0.54 and 9.76±0.89 h and the total body clearance(Cl) was 1.15±0.05, 1.18±0.03 and 1.17±0.07 m L · min-1 · kg-1, respectively. The maximum plasma concentration(Cmax, 36.50±1.40, 76.11±2.77 and 182.05±7.20 ng · m L-1, respectively) and the area under the first-moment curve(AUC-10→∞, 985.83±49.46, 1 663.12±51.42 and 3 558.04±197.88 mg · h · L, respectively) increased accordingly to the administered dose rates; the oral bioavailabilities were estimated to be 88.61%, 74.75% and 79.96%, respectively. The values of fu were 0.12%, 0.14% and 0.13% in dog plasma, respectively. In conclusion, the pharmacokinetics of milbemycin oxime in dogs following oral administration revealed its higher oral bioavailability and advantageous pharmacokinetic properties, such as its lower total body clearance and longer elimination half-life, and indicated that the single oral dose of 0.50 mg · kg-1 of milbemycin oxime which was recommended in all the parasitological efficacy studies allowed an adequate concentration of the drug. 展开更多
关键词 PHARMACOKINETIC MACROLIDE milbemycin oxime oral administration DOG
下载PDF
A Study on Early Biological Effects of Oral Administration of Terephthalic Acid in Rats
5
作者 Qiu Qing, et al. ACTA ACADEMIAE MEDICINAF,NANJING,1994,14(2):131-133 《The Journal of Biomedical Research》 CAS 1994年第1期74-74,共1页
Rats were fed with foods containing various doses of terephthalic (TPA) for 8 weeks. General status was observed and biological indices(including urine,serum and bone) were determined after 1, 3 and 8 week administrat... Rats were fed with foods containing various doses of terephthalic (TPA) for 8 weeks. General status was observed and biological indices(including urine,serum and bone) were determined after 1, 3 and 8 week administration.Differences in urine calcium, ammonia, PH and serum albumin between the treat groups and the control were significant. Marked correlation was found in these indices. No Change in N-acetyl-β-D-glucosaminidase (NAG),serum calcium,bone calcium, alkaline phosphatase and alanine transaminase was noted in the treat groups.It suggests that change of urine ammonium concentration may serve as a protective level in setting the TPA exposure limit. 展开更多
关键词 terphthalic acid oral administration biological effect rat
下载PDF
The 30-Day Oral Administration Studies of Liposoluble Tea Polyphenols in Rats 被引量:2
6
作者 Liang-Peng Lin Da Sun +4 位作者 Yue-Fei Wang Da-Wei Li Shi-Kang Zhang Yue-Jin Zhu Pu-Ming He 《茶叶》 2013年第4期325-332,共8页
Tea polyphenols is a natural antioxidant with a variety of biological activity.However,the weak liposolubility and low bioavailability limit their application.As a result,structural modification of tea polyphenols com... Tea polyphenols is a natural antioxidant with a variety of biological activity.However,the weak liposolubility and low bioavailability limit their application.As a result,structural modification of tea polyphenols comes into being.The prepared liposoluble tea polyphenols was suggested as a good candidate antioxidant for edible-oil and fats products.But,safety studies on liposoluble tea polyphenols are limited.The objective of the present study was conducted to synthesize liposoluble tea polyphenols and evaluate its toxicity in Sprague-Dawley rats on oral administration at dietary levels of 1,2 and 4% for 30 days.There were no adverse effects on general condition,growth,food intake,feed conversion efficiency,haematology parameters,clinical chemistry values and organ weights.High-dose males exhibited a higher haemoglobin concentration and a lower alanine aminotransferase levels,and high-dose females showed a lower albumin and globulin levels.These slight changes were considered of no toxicological significance.Necropsy and histopathology findings revealed no treatment-related changes in any of the organs.Thus,the results allowed us to conclude that the liposoluble tea polyphenols properly utilized in the oral administration could be devoid of any toxic risk. 展开更多
关键词 脂溶性茶多酚 口服给药 SPRAGUE-DAWLEY 大鼠 天然抗氧化剂 血红蛋白浓度 器官重量 生物利用度
下载PDF
Acute Toxicity of Aluminium Phosphide Following Oral Administration in Rats
7
作者 OM KUMAR K. SUGENDRAN +2 位作者 S. C. PANT RAM SINGH P. M. K. REDDY AND R. VIJAYARAGHAVAN (Division of Pharmacology and Toxicology, Defence Research and Development Establishment, GWALIOR-474002, India) 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 1998年第2期179-186,共8页
Aluminium phosphide (AlP) is used as a fumigant and also sometimes misused for suicidal attempts in India, due to its easy availability. The effect of phosphine, the gas that is liberated when AlP comes in contact wit... Aluminium phosphide (AlP) is used as a fumigant and also sometimes misused for suicidal attempts in India, due to its easy availability. The effect of phosphine, the gas that is liberated when AlP comes in contact with moisture, is well documented in the literature. However, the effect of AlP in its native form on animal models is not well cited. In this study we examined the acute toxic effect of AlP in rats. Oral LD50 of AlP for male and female rats were found to be 14. 13 and 11. 89mg/kg, respectively. Oral administration of an AlP dose of 0. 80 LD50 resulted in significant increases in the level of plasma glutamic oxaloacetic transaminase,alkaline phosphatase, glucose and urea in rats of both sexes. Hemoglobin level and packed cell volume also increased significantly 6h after administration. Body weight was reduced but the organ to body weight ratio of lung, liver, spleen, kidney and testes remained unchanged.Histopathological changes induced by AlP during 24-48h induced hemorrhage, congestion and mild to moderate atrophy of various cellular components of visceral organs. The study showed that the acute toxic effect of AlP may be due to hypovolemic shock. Female rats were found to be more susceptible than were males. 展开更多
关键词 In Acute Toxicity of Aluminium Phosphide Following oral administration in Rats
下载PDF
Therapeutic Effect of Oral Administration and External Therapy of Traditional Chinese Medicine on Cervical Tuberculous Lymphadenopathy
8
作者 Guoqiang Yang Jin Zhang 《Journal of Clinical and Nursing Research》 2019年第3期7-10,共4页
Objective:To analyze the clinical effect and value of oral administration and external therapy of traditional Chinese medicine for treatment of cervical tuberculous lymphadenopathy.Methods:A total of 56 patients with ... Objective:To analyze the clinical effect and value of oral administration and external therapy of traditional Chinese medicine for treatment of cervical tuberculous lymphadenopathy.Methods:A total of 56 patients with cervical tuberculous lymphadenopathy admitted to our hospital from January 1 to January 2018 were recruited.By using double-blind method,the patients were divided into control group(n=28)and experimental group(n=28).Control group comprised of patients with conventional anti-tuberculosis treatment,while the experimental group comprised of patients treated with oral administration and external therapy of traditional Chinese medicine.Total effective rate,incidence of complication and level of T lymphocyte subsets were compared between the two groups of cervical tuberculous lymphadenopathy patients.Results:Post-treatment data of total effective rate,complication rate,CD3+,CD4+,CD8+,CD4+/CD8+of the experimental group were compared with the control group.P<0.05;statistical analysis showed statistical significance.Post-treatment data of CD3+,CD4+,CD8+,CD4+/CD8+of both control and experimental groups were compared with pre-treatment data.P<0.05;statistical analysis showed statistical significance.Conclusion:Oral administration and external therapy of traditional Chinese medicine possesses significant effect in treatment of cervical tuberculous lymphadenopathy. 展开更多
关键词 oral administration and external therapy of traditional Chinese MEDICINE CERVICAL TUBERCULOUS LYMPHADENOPATHY clinical effect
下载PDF
Fifty-six Cases of Stubborn Eczema Treated by Oral Administration and Topical Application of Herbal Medicine
9
作者 罗维丹 WuChenglin +1 位作者 邬成霖 董敏华 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2001年第4期259-260,共2页
Eczema is a kind of very common dermatopathy. The cases with a long course of illness and hard to be cured are termed as stubborn eczema. We have obtained good results in its treatment since 1995 with the Chu Shi Tan... Eczema is a kind of very common dermatopathy. The cases with a long course of illness and hard to be cured are termed as stubborn eczema. We have obtained good results in its treatment since 1995 with the Chu Shi Tang (除湿汤Dampness-Clearing Decoction) for oral intake and the Fu Fang Ku Shen Xi Ye (复方苦参洗液) for topical application. The following is a clinical report for treating 56 patients with stubborn eczema. 展开更多
关键词 管理 口头 管理 热门 青少年 成年人 变老 孩子 孩子 幼儿园 汉语草药 湿疹 女性 男性 中年
下载PDF
Clinical Observation on Treatment of Acquired Paralytic Strabismus by Acupuncture Plus Oral Administration of Chinese Herbs
10
作者 元旭红 周永生 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2003年第3期188-190,共3页
From June 1996 to June 2002, the author treated 38 cases of acquired paralytic strabismus by acupuncture plus oral administration of Zheng Rong Tang (正容汤), with another 38 cases of acquired paralytic strabismus tre... From June 1996 to June 2002, the author treated 38 cases of acquired paralytic strabismus by acupuncture plus oral administration of Zheng Rong Tang (正容汤), with another 38 cases of acquired paralytic strabismus treated only with oral administration of Chinese herbs as the controls. The results are reported as follows. 展开更多
关键词 斜视 面肌瘫痪 中医药疗法 针刺疗法 正容汤
下载PDF
住院患者口服用药医嘱点评与分析
11
作者 陈福安 姚晨蕊 +3 位作者 张呈 黄伟 张亚同 叶爱军 《中国临床保健杂志》 CAS 2024年第3期330-332,共3页
目的分析住院患者口服用药的医嘱点评结果。方法将2018年1月至2023年1月北京医院收治的9000例住院患者(9000张处方)作为研究对象,由临床药师对其口服用药处方进行医嘱点评,分析医嘱点评结果,包括不合理处方的发生率、时间分布、科室分... 目的分析住院患者口服用药的医嘱点评结果。方法将2018年1月至2023年1月北京医院收治的9000例住院患者(9000张处方)作为研究对象,由临床药师对其口服用药处方进行医嘱点评,分析医嘱点评结果,包括不合理处方的发生率、时间分布、科室分布、不合理用药原因及医嘱书写不规范发生情况。结果9000张处方中,不合理处方张数为176张,不合理处方发生率为1.96%;住院患者口服用药不合理处方的时间分布,以2018年的不合理发生率最高(2.32%),2022—2023年的发生率最低(1.69%);住院患者口服用药不合理处方的科室分布中,以肿瘤科的不合理发生率最高(4.01%),外科的发生率最低(1.21%);住院患者口服用药不合理处方的原因中,未按药品临床应用管理规定用药最为常见,构成比为23.86%,超医嘱用药最为少见,构成比为3.98%;9000张处方中,医嘱书写不规范处方共849张,发生率为9.43%,其中包括药品名称387张、剂型规格273张、用法用量189张。结论住院患者口服用药不合理情况较为常见,应引起重视,加强用药管理。 展开更多
关键词 处方不当 投药 口服 住院病人
下载PDF
口服尖吻蝮蛇毒降纤酶对大鼠纤维蛋白原的影响
12
作者 陶秀珍 张学荣 +4 位作者 廖明 李牡艳 孔露平 张昊 罗小玲 《广西医科大学学报》 CAS 2024年第2期255-259,共5页
目的:探讨尖吻蝮蛇毒降纤酶(DF)灌胃给药后在SD大鼠胃肠道内的分布情况及对血浆纤维蛋白原浓度的变化情况。方法:SD大鼠灌胃尖吻蝮蛇毒DF后观察大鼠体征,检测DF对大鼠的急性毒性作用;采用免疫组织化学法和酶联免疫吸附试验(ELISA)法检... 目的:探讨尖吻蝮蛇毒降纤酶(DF)灌胃给药后在SD大鼠胃肠道内的分布情况及对血浆纤维蛋白原浓度的变化情况。方法:SD大鼠灌胃尖吻蝮蛇毒DF后观察大鼠体征,检测DF对大鼠的急性毒性作用;采用免疫组织化学法和酶联免疫吸附试验(ELISA)法检测尖吻蝮蛇毒DF在大鼠胃肠道组织中的分布情况及其与大鼠纤维蛋白原的量效关系和时效关系。结果:灌胃尖吻蝮蛇毒DF(1000 U/kg)后大鼠未出现明显的中毒反应,DF口服毒性很低;大鼠灌胃DF 3 h后,DF主要存在于十二指肠、胃和空肠组织内;在量效关系实验中,大鼠灌胃DF(200 U/kg)后纤维蛋白原水平显著低于对照组(P<0.05);在时效关系实验中,灌胃第5、第6、第7天的纤维蛋白原水平显著低于对照组(P<0.05),并呈时间和剂量依赖关系。结论:口服尖吻蝮蛇毒DF可以通过胃肠道黏膜吸收进入胃、十二指肠、空肠组织内;口服适量DF可以有效降低大鼠体内的纤维蛋白原水平,连续给药效果更为显著。 展开更多
关键词 尖吻蝮蛇毒 降纤酶 纤维蛋白原 口服给药 静脉注射
下载PDF
加味宣痹汤内服外洗结合免疫抑制剂治疗湿热痹阻证类风湿性关节炎患者的疗效观察
13
作者 王旭 吴金友 +4 位作者 戎蓉 连博 郝芬丽 乔银银 范兴刚 《世界中西医结合杂志》 2024年第6期1222-1226,共5页
目的探讨加味宣痹汤内服外洗结合免疫抑制剂治疗湿热痹阻证类风湿性关节炎(Rheumatoid arthritis,RA)患者的临床疗效。方法选取2018年12月—2022年12月期间阜阳市第五人民医院中医科收治的湿热痹阻证RA患者102例作为研究对象,按随机单... 目的探讨加味宣痹汤内服外洗结合免疫抑制剂治疗湿热痹阻证类风湿性关节炎(Rheumatoid arthritis,RA)患者的临床疗效。方法选取2018年12月—2022年12月期间阜阳市第五人民医院中医科收治的湿热痹阻证RA患者102例作为研究对象,按随机单双数法分为对照组和试验组,每组各51例。对照组予为期3个月的免疫抑制剂治疗,试验组在对照组基础上联合加味宣痹汤内服外洗治疗。观察比较两组患者治疗前后中医证候积分、28处关节疾病活动度分数(Disease activity score of 28 joints,DAS28)、骨性关节炎指数(Western ontario and mcmaster universities osteoarthritis index,WOMAC)、类风湿因子(Rheumatoid factor,RF)、血沉(Erythrocyte sedimentation rate,ESR)、C反应蛋白(C-reactive protein,CRP)水平,并评估临床疗效及不良反应情况。结果治疗后两组患者屈伸不利、肿胀、疼痛、压痛积分均较治疗前降低,差异有统计学意义(P<0.05);且试验组中医证候积分明显低于对照组,差异有统计学意义(P<0.05)。治疗后两组患者DAS28、WOMAC评分均较治疗前降低,差异有统计学意义(P<0.05);且试验组DAS28、WOMAC评分均明显低于对照组,差异有统计学意义(P<0.05)。治疗后两组患者RF、ESR、CRP水平均较治疗前降低,差异有统计学意义(P<0.05);且试验组RF、ESR、CRP水平均明显低于对照组,差异有统计学意义(P<0.05)。治疗后试验组临床总有效率97.78%(44/45)明显高于对照组82.98%(39/47),差异有统计学意义(P<0.05)。治疗期间,试验组不良反应率4.44%(2/45)明显低于对照组19.15%(9/47),差异有统计学意义(P<0.05)。结论加味宣痹汤内服外洗结合免疫抑制剂应用于RA湿热痹阻证具有增效减毒、缓解症状、减轻疾病活动度、调节炎症及血沉的作用。 展开更多
关键词 类风湿性关节炎 免疫抑制剂 加味宣痹汤 内服外洗 湿热痹阻证
下载PDF
《鼓励研发申报儿童药品清单》口服药品有效成分在某儿童专科医院住院患儿中药物剂型可接受性情况调查
14
作者 肖梦微 朱琳 +1 位作者 王广飞 李智平 《中国医药指南》 2024年第15期109-112,共4页
目的 分析《鼓励研发申报儿童药品清单》中的口服药物成分在某三甲儿童专科医院不同年龄段患儿中的实际应用及该院目前配备剂型适宜性的情况。方法 从4批《鼓励研发申报儿童药品清单》中的口服液体制剂的有效成分中,选取某三级儿童专科... 目的 分析《鼓励研发申报儿童药品清单》中的口服药物成分在某三甲儿童专科医院不同年龄段患儿中的实际应用及该院目前配备剂型适宜性的情况。方法 从4批《鼓励研发申报儿童药品清单》中的口服液体制剂的有效成分中,选取某三级儿童专科医院目前有该活性成分的口服药物,分析2023年11月9日至2023年12月8日住院患儿使用这些药物的调剂频次及用药时的年龄。基于我国《儿童用药(化学药品)药学开发指导原则(试行)》提出的不同年龄段儿科人群用药可接受的剂型选择,针对不同年龄组(新生儿、婴幼儿、学龄前儿童、学龄儿童、青少年),评估各药物的剂型适宜性。结果 在2023年11月9日至2023年12月8日时间段内,该院住院患儿使用过含4批《鼓励研发申报儿童药品清单》中的口服液体制剂的有效成分的口服药物共14种。在14种药物(片剂或胶囊剂)的4542次调剂记录中,新生儿和婴幼儿均为剂型“不适宜”,分别为132次和1111次;此2个年龄段使用频次最高的药物为左甲状腺素钠片、螺内酯片、熊去氧胆酸胶囊。对于学龄前儿童,适宜程度为“适用但存在问题”的胶囊剂共992次,其余为可“适用但不优选”的片剂1327次;对于学龄儿童,均为“适用”;对于青少年,均为“最优选”。“不适宜”或“适用但存在问题”的用药次数占总次数的49.2%。对各药物的剂型适宜性得分计算加权平均,剂型适宜性最低的药物分别为左甲状腺素钠片、熊去氧胆酸胶囊、他克莫司胶囊。结论 《鼓励研发申报儿童药品清单》中的口服液体制剂对应的片剂或胶囊剂在该院新生儿和婴幼儿中均有一定的应用,且剂型适宜性较低。医疗机构应当进一步加强儿童用药遴选与配备。对于新生儿及婴幼儿,需要加急研发他们常用药物的剂型以及分剂量调配的相关规范。 展开更多
关键词 剂型 口服给药 新生儿 婴儿 学龄前儿童 药物调剂
下载PDF
慢性便秘的结肠镜检查前肠道准备口服药物研究进展 被引量:1
15
作者 黄涵 蔡妍 +1 位作者 陈卫建 吴凌康 《新医学》 CAS 2024年第4期255-259,共5页
充分的肠道准备是结肠镜检查的前提,而慢性便秘(CC)是肠道准备的重要影响因素之一。近年来学者们越来越重视CC的肠道准备方案。文章就CC结肠镜检查前的肠道清洁剂选择的临床研究进行综述,分析各方案的有效性和安全性,旨在为临床实践提... 充分的肠道准备是结肠镜检查的前提,而慢性便秘(CC)是肠道准备的重要影响因素之一。近年来学者们越来越重视CC的肠道准备方案。文章就CC结肠镜检查前的肠道清洁剂选择的临床研究进行综述,分析各方案的有效性和安全性,旨在为临床实践提供参考,从而提高CC的肠道准备质量,及时对结直肠癌进行三级预防。 展开更多
关键词 慢性便秘 结直肠癌 结肠镜检查 肠道准备 口服给药
下载PDF
增液汤内服及离子导入治疗阴液亏虚证功能性便秘临床研究
16
作者 章新祎 杨丹华 李秀燕 《新中医》 CAS 2024年第8期46-50,共5页
目的:观察增液汤内服及离子导入治疗阴液亏虚证功能性便秘(FC)的临床疗效及对胃肠功能的影响。方法:选取87例阴液亏虚证FC为研究对象。根据随机数字表法分为观察组44例与对照组43例。对照组给予乳果糖口服溶液治疗,观察组给予增液汤内... 目的:观察增液汤内服及离子导入治疗阴液亏虚证功能性便秘(FC)的临床疗效及对胃肠功能的影响。方法:选取87例阴液亏虚证FC为研究对象。根据随机数字表法分为观察组44例与对照组43例。对照组给予乳果糖口服溶液治疗,观察组给予增液汤内服及离子导入治疗。比较2组临床疗效、中医证候评分、胃肠功能血清学指标[胃动素(MTL)、D-乳酸(D-LA)、胃泌素(GAS)、血管活性肠肽(VIP)]改善情况及不良反应发生率。结果:观察组总有效率为97.73%,对照组为86.05%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组中医证候中主症、次症评分及总评分均较治疗前减少(P<0.05),且观察组上述各项评分均低于对照组(P<0.05)。治疗后,2组血清MTL水平较治疗前升高(P<0.05),血清D-LA、GAS、VIP水平较治疗前降低(P<0.05);且观察组MTL水平高于对照组(P<0.05),D-LA、GAS、VIP水平低于对照组(P<0.05)。治疗期间,观察组不良反应总发生率为4.55%,对照组为18.60%,2组比较,差异有统计学意义(P<0.05)。结论:增液汤内服及离子导入治疗阴液亏虚证FC,有助于缓解患者临床症状,改善胃肠功能,其疗效及安全性均优于西医常规治疗。 展开更多
关键词 功能性便秘 增液汤 阴液亏虚证 内服 离子导入 胃肠功能
下载PDF
托里透毒汤口服联合紫草纱条引流促进肛周脓肿术后创面愈合的研究
17
作者 王燕燕 梁想 +3 位作者 李玲玲 马玉超 刘红振 位艳赏 《中华中医药学刊》 CAS 北大核心 2024年第4期243-247,共5页
目的探讨托里透毒汤方口服联合紫草纱条创面引流促进肛周脓肿患者术后创面愈合和影响炎性因子表达研究。方法选取医院2019年6月—2022年1月收治的174例肛周脓肿术的患者为研究对象,随机分为观察组(58例)、对照组A(58例)和对照组B(58例)... 目的探讨托里透毒汤方口服联合紫草纱条创面引流促进肛周脓肿患者术后创面愈合和影响炎性因子表达研究。方法选取医院2019年6月—2022年1月收治的174例肛周脓肿术的患者为研究对象,随机分为观察组(58例)、对照组A(58例)和对照组B(58例),术后所有患者给予常规处理,对照组A增加紫草纱条创面引流治疗,对照组B增加凡士林纱条创面引流治疗,观察组增加托里透毒汤方口服与紫草纱条创面引流联合治疗。比较3组患者术后第1、7、14天时疼痛程度、创面症状评分、创面愈合情况、炎性因子水平及治疗效果。结果术后第7、14天观察组血清P物质(Substance P,SP)、五羟色胺(5-Hydroxytryptamine,5-HT)水平均低于对照组A与对照组B(P<0.05),对照组A第7、14天各水平均低于对照组B(P<0.05);术后第7、14天观察组分泌物评分、水肿评分均低于对照组A与对照组B(P<0.05),对照组A7 d、14 d各评分均低于对照组B(P<0.05);观察组第7、14天创面缩小率高于对照组A与对照组B(P<0.05),对照组A第7、14天缩小率均高于对照组B,治疗后观察组创面腐肉全部脱落时间与创面愈合时间均短于对照组A与对照组B(P<0.05),对照组A各时间均低于对照组B(P<0.05);术后第7、14天观察组血清肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)、C反应蛋白(C-reactive Protein,CRP)及白细胞介素-6(Interleukin-6,IL-6)炎性因子水平均低于对照组A与对照组B(P<0.05),对照组A第7天、14天各水平均低于对照组B(P<0.05);治疗后观察组患者总有效58例(100.00%)显著比对照组A患者54例(93.10%)和对照组B患者50例(86.21%)高(P<0.05),对照组A总有效率比对照组B高,但两组比较差异不存在统计学意义(P>0.05)。结论托里透毒汤口服联合紫草纱条创面引流可以促进术后创面愈合,降低炎性因子水平,缩短康复进程,值得推广。 展开更多
关键词 托里透毒汤 中药口服 紫草纱条 肛周脓肿 创面愈合 炎性因子
下载PDF
不同治疗方法对复发性流产患者血清同型半胱氨酸水平的影响及临床意义
18
作者 陈誉尹 赵淑云 +4 位作者 田维婷 梁耀允 李伟霞 钟兴明 黄官友 《贵州医科大学学报》 CAS 2024年第4期615-619,共5页
目的探讨肌肉注射维生素B12及口服复合维生素治疗血清同型半胱氨酸(HCY)升高的复发性流产(RSA)患者的疗效。方法选取HCY升高的RSA患者137例作为研究对象,分为注射组(肌肉注射维生素B12)和口服组(口服爱乐维复合维生素片),收集2组患者的... 目的探讨肌肉注射维生素B12及口服复合维生素治疗血清同型半胱氨酸(HCY)升高的复发性流产(RSA)患者的疗效。方法选取HCY升高的RSA患者137例作为研究对象,分为注射组(肌肉注射维生素B12)和口服组(口服爱乐维复合维生素片),收集2组患者的年龄、自然流产次数、抗核抗体谱(ANA)、血清D-二聚体水平等一般资料,比较2组患者治疗前后HCY水平、治疗后HCY正常的百分率、HCY降至正常的时间、低分子肝素使用率、妊娠率、保胎成功率、抱婴率及妊娠合并症。结果与口服组比较,治疗后注射组患者HCY水平明显降低(P=0.002),HCY正常的百分率明显升高(P=0.042),HCY降至正常的时间明显缩短(P<0.001),妊娠率及抱婴率均明显升高(P<0.05),妊娠合并症的发生率明显降低(P=0.003)。结论与口服复合维生素治疗比较,肌肉注射维生素B12治疗HCY升高的RSA患者,能在较短时间内有效降低血清HCY水平,更能够改善患者的临床结局及减少妊娠合并症。 展开更多
关键词 复发性流产 维生素B12 同型半胱氨酸 口服 肌肉注射 妊娠结局
下载PDF
Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensinⅡ-induced hypertension in mice 被引量:2
19
作者 Kegong Tang Xiaona Wang +10 位作者 Yu Zhao Xiaobei Li Zhenyu Jiang Song Mei Mingrui Chen Yiming Ma Xinyi Du Xiangyu Qiao Na Sun Jiaqi Liu Chengyu Jiang 《Science China(Life Sciences)》 SCIE CAS CSCD 2023年第10期2370-2379,共10页
Hypertension has become a growing public health concern worldwide.In fact,hypertension is commonly associated with increased morbidity and mortality.Currently,oligonucleotide drugs have proven to be promising therapeu... Hypertension has become a growing public health concern worldwide.In fact,hypertension is commonly associated with increased morbidity and mortality.Currently,oligonucleotide drugs have proven to be promising therapeutic agents for various diseases.In the present study,we aimed to demonstrate that a herbal small RNA(s RNA),XKC-sRNA-h3(B55710460,F221.I000082.B11),exhibits potent antihypertensive effects by targeting angiotensin-converting enzyme(ACE)in mice.When compared with captopril,oral administration of the sphingosine(d18:1)-XKC-s RNA-h3 bencaosome more effectively prevented angiotensin II-induced hypertensive cardiac damage and alleviated kidney injury in mice.Such findings indicated that XKC-sRNA-h3 may be a novel orally available ACE inhibitor type oligonucleotide drug for hypertension. 展开更多
关键词 HYPERTENSION oligonucleotide drug oral administration
原文传递
养殖场的蝇类危害及防控方法
20
作者 孙雪峰 李巧丽 +2 位作者 刘希望 李剑勇 杨亚军 《中兽医医药杂志》 2024年第1期82-86,共5页
蝇类是重要的病媒昆虫,其幼虫可在养殖场的粪便及未经处理的动物尸体中大量孳生。圈舍内的大量蝇虫可通过影响畜禽休息和吸食血液等方式袭扰牲畜,降低其生产性能。更重要的是,蝇类的体表和体内可携带大量致病菌、病毒、寄生虫及虫卵等... 蝇类是重要的病媒昆虫,其幼虫可在养殖场的粪便及未经处理的动物尸体中大量孳生。圈舍内的大量蝇虫可通过影响畜禽休息和吸食血液等方式袭扰牲畜,降低其生产性能。更重要的是,蝇类的体表和体内可携带大量致病菌、病毒、寄生虫及虫卵等病原体;蝇虫具有边食、边吐、边排的习性,可机械性地传播各种病原体,是很多疾病的重要媒介。另外,一些蝇类的幼虫本身就是蝇蛆症的病原。因此,种群数量不受控制的蝇类可对畜禽和人类的健康造成严重威胁。养殖场蝇类的综合防控措施包括环境治理、化学防治、生物防治、物理或机械防治等。口服抗蝇蛆药是化学防治的一种,该类药物为昆虫生长调节剂,对畜禽毒性较低,混饲给药后在肠道吸收极少,随粪便排出,可阻断粪便中蝇蛆的发育而减少成蝇的数量。目前,常用的畜禽口服抗蝇蛆药有环丙氨嗪、除虫脲。本文综述了蝇类害虫的主要生物学习性、对养殖业的危害、综合防控措施以及口服抗蝇蛆药的应用情况,以期为养殖业的蝇害综合防控提供帮助,为口服抗蝇蛆药的开发提供参考。 展开更多
关键词 养殖场 蝇类 危害 防控 口服杀蝇蛆药
下载PDF
上一页 1 2 61 下一页 到第
使用帮助 返回顶部